메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

IR

Press Releases
Huonslab in the News
Announcement [게시판]
Download

Huonslab has submitted the Biologics License Application for Recombinant Human Hyaluronidase ‘HYDIZYME™ Injection’ - Applying HyDIFFUZE™ technology… Aiming for Approval in 2026 -

22 Dec 2025
Read More

Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidase Product, HYDIZYME™

30 Jul 2025
Read More

Huonslab presents its remarkable formulation conversion technology at BIO USA

17 Jun 2025
Read More

Huonslab Achieves ‘Last-Patient-In (LPI)’ in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20 (rHuPH20)

09 Jun 2025
Read More

Huonslab Announced the Results of HLB3-002 Formulation Conversion Study in a Poster Presentation at 2025 AACR

29 Apr 2025
Read More

Huonslab Announces Positive Results from Non-Clinical PK Comparative Study of Trastuzumab Co-formulated with HyDIFFUZE™

04 Sep 2024
Read More

Huonslab Receives IND Approval from MFDS to Start Pivotal Clinical Trial for ‘Recombinant Human

07 Aug 2024
Read More

Huonslab registers patent for recombinant human hyaluronidase technology

23 Jul 2024
Read More